| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.004 |